A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs-Reference-Cited by-同舟云学术

A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs

Published:2008-03 Issue:3 Volume:8 Page:401-413
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Davda Jasmine P.,Jain Maneesh,Batra Surinder K.,Gwilt Peter R.,Robinson Dennis H.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions;Reilly;Clin Pharmacokinet,1995

2. Monoclonal antibodies in diagnosis and therapy;Waldmann;Science,1991

3. Transport of molecules across tumor vasculature;Jain;Cancer Metastasis Rev,1987

4. Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors;Beckman;Cancer,2007

5. Single-chain antibodies in pancreatic cancer;Colcher;Ann N Y Acad Sci,1999

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translational two-pore PBPK model to characterize whole-body disposition of different-size endogenous and exogenous proteins;Journal of Pharmacokinetics and Pharmacodynamics;2024-05-01

2. A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiology;Physica Medica;2024-03

3. Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET;EJNMMI Research;2024-02-15

4. Factors affecting peptide and protein absorption, metabolism, and excretion;Peptide and Protein Drug Delivery Using Polysaccharides;2024

5. A physiologically based pharmacokinetic model for V937 oncolytic virus in mice;Frontiers in Pharmacology;2023-09-13